Paper - WANFANG MED ONLINE

You Position: Home > Paper

Atrial fibrillation in the elderly

( views:52, downloads:8 )

Author:: No author available

Journal Title:: JOURNAL OF GERIATRIC CARDIOLOGY

Issue:: 2

DOI:: 10.3724/SP.J.1263.2011.12293

Key Word:: Atrial fibrillation;Heart failure;Thrombo-embolism;Treatment;Prevention

Abstract： This review discusses atrial fibrillation according to the guidelines of Brazilian Society of Cardiac Arrhythmias and the Brazilian Cardiogeriatrics Guidelines. We stress the thromboembolic burden of atrial fibrillation and discuss how to prevent it as well as the best way to conduct cases of atrial fibrillatios in the elderly, reverting the arrhythmia to sinus rhythm, or the option of heart rate control. The new methods to treat atrial fibrillation, such as radiofrequency ablation, new oral direct thrombin inhibitors and Xa factor inhibitors, as well as new antiarrhythmic drugs, are depicted.

Reference

[1]Arnold, Pinter,Paul, Dorian.New approaches to atrial fibrillation management: treat the patient, not the ECG.[J].2010,28(5).
[2]E, Braunwald.Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.[J].1997,337.
[3]Gage BF,Shannon W,Radford MJ,etc.Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.[J].2001,285(22).
[4]Luciana Armaganijan,John Eikelboom,Jeff S. Healey.New Pharmacotherapy for Stroke Prevention in Atrial Fibrillation: Update 2010[J].2009,26(12).
[5]A John, Camm,Paulus, Kirchhof,Gregory Y H, Lip,etc.Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).[J].2010,12.
[6]Stollberger, Claudia,Chnupa, Pavel,Kronik, Gerhard,etc.Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation.[J].1998,128(8).
[7]E M, Hylek,S J, Skates,M A, Sheehan,etc.An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.[J].1996,335(8).
[8]Vasan RS,Wang TJ,Benjamin EJ,etc.Obesity and the risk of new-onset atrial fibrillation.[J].2004,292(20).
[9]Monica, Patten,Renke, Maas,Peter, Bauer,etc.Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial.[J].2004,25.
[10]Pogue J,Connolly SJ,Hart RG.Effect of clopidogrel added to aspirin in patients with atrial fibrillation.[J].2009,360(20).
[11]de Vos CB,Crijns HJ,Lip GY,etc.A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.[J].2010,138(5).
[12]Stefan Knecht,Christian Oelschlager,Thomas Duning.Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy[J].2008,29(17).
[13]Wolf P. A.,Abbott R. D.,Kannel W. B..Atrial fibrillation as an independent risk factor for stroke: the Framingham Study[J].1991.
[14]R G, Hart,O, Benavente,R, McBride,etc.Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.[J].1999,131(7).
[15]DiMarco JP,Rosenberg Y,Kellen JC,etc.A comparison of rate control and rhythm control in patients with atrial fibrillation.[J].2002,347(23).
[16]K M, Flegel.From delirium cordis to atrial fibrillation: historical development of a disease concept.[J].1995,122(11).
[17]J L, Cobler,M E, Williams,P, Greenland.Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation.[J].1984,144.
[18]C J, Lanzarotti,B, Olshansky.Thromboembolism in chronic atrial flutter: is the risk underestimated?[J].1997,30(6).
[19]Duray GZ,Ehrlich JR,Hohnloser SH.Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.[J].2010,25(1).
[20]E J, Benjamin,P A, Wolf,R B, D'Agostino,etc.Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.[J].1998,98.
[21]Hart RG,Flaker G,De-Caterina R,etc.Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).[J].2008,39(5).
[22]Yoko, Miyasaka,Marion E, Barnes,Ronald C, Petersen,etc.Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort.[J].2007,28.
[23]Lip GY,Nieuwlaat R,Pisters.Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.[J].2010,137(2).
[24]Valentin Fuster,Lars E. Rydén,Richard W. Asinger,etc.ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guide[J].2001,38(4).
[25]Roy D,Capucci A,Hohnloser SH,etc.Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.[J].2007,357(10).
[26]Falk RH u.edu.Atrial fibrillation.[J].2001,344(14).
[27]Iguchi Y,Kimura K,Shibazaki K,etc.Annual incidence of atrial fibrillation and related factors in adults.[J].2010,106(8).
[28].Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions[J].1992.
[29]Parkash R,Verma A,Tang AS.Persistent atrial fibrillation: current approach and controversies.[J].2010,25(1).
[30]Breteler MM,van Harskamp F,Grobbee DE,etc.Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.[J].1997,28(2).
[31]Go AS,Pomernacki NK,Chang Y,etc.A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.[J].2011,58(4).
[32]Brugada, Ramon,Tapscott, Terry,Czernuszewicz, Grazyna Z.,etc.Identification of a Genetic Locus for Familial Atrial Fibrillation.[J].1997,336(13).
[33]Robert G, Hart,Lesly A, Pearce,Maria I, Aguilar.Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.[J].2007,146(12).
[34]Josephson ME,Noheria A,Wylie-JV Jr,etc.Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review.[J].2008,168(6).
[35]J J, Leonard,J, Shaver,M, Thompson.Left atrial transport function.[J].1981,92.
[36]Benjamin, Emelia J.,Levy, Daniel.Independent risk factors for atrial fibrillation in a population-based cohort.[J].1994,271(11).
[37]C D, Furberg,B M, Psaty,T A, Manolio,etc.Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).[J].1994,74(3).
[38]M. Khaled Sabeh,Calum A. MacRae.The genetics of atrial fibrillation[J].2010,25(3).
[39]A, Alaud-din,S, Meterissian,R, Lisbona,etc.Assessment of cardiac function in patients who were morbidly obese.[J].1990,108.
[40]Takahashi A,Haissaguerre M,Jais P,etc.Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.[J].1998,339(10).
[41]Phillips KA,Jensvold NG,Chang Y,etc.Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?[J].2003,290(20).
[42]Connolly SJ,Crijns HJ,Page RL,etc.Effect of dronedarone on cardiovascular events in atrial fibrillation.[J].2009,360(7).
[43]Marcucci M,Iorio A,Nobili A,etc.Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards.[J].2010,21(6).
[44]Tracy CM,Ezekowitz MD,Curtis AB,etc.2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.[J].2011,57(11).